Which of the following treatments is contraindicated in a patient with hemophilia?

Explanation

In hemophilic patients, Factor VIII concentrate, cryoprecipitate, and EACA are commonly used to manage bleeding episodes. However, platelet factor is not recommended because it does not address the underlying clotting factor deficiency and may be ineffective or harmful.